20012022
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Streptomyces rimosus Medicine & Life Sciences
Streptomyces Medicine & Life Sciences
Oxytetracycline Medicine & Life Sciences
Streptomyces coelicolor Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Genes Medicine & Life Sciences
Tetracycline Medicine & Life Sciences
Metabolic Engineering Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2022

Research Output 2001 2018

4 Citations

Expanding primary metabolism helps generate the metabolic robustness to facilitate antibiotic biosynthesis in Streptomyces

Schniete, J. K., Cruz-Morales, P., Selem-Mojica, N., Fernández-Martínez, L. T., Hunter, I. S., Barona-Gómez, F. & Hoskisson, P. A., 6 Feb 2018, In : mBio. 9, 13 p., e02283-17

Research output: Contribution to journalArticle

Open Access
File
Streptomyces
Pyruvate Kinase
Anti-Bacterial Agents
Gene Duplication
Genome
14 Citations

Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering

Lešnik, U., Lukežič, T., Podgoršek, A., Horvat, J., Polak, T., Šala, M., Jenko, B., Harmrolfs, K., Ocampo-Sosa, A., Martínez-Martínez, L., Herron, P. R., Fujs, Š., Kosec, G., Hunter, I. S., Müller, R. & Petković, H., 23 Mar 2015, In : Angewandte Chemie International Edition. 54, 13, p. 3937-3940 4 p.

Research output: Contribution to journalArticle

Open Access
File
Tetracyclines
Antibiotics
Tetracycline
Lead
Anti-Bacterial Agents

Activities 2008 2009

  • 2 Membership of board
  • 1 Membership of committee

Acies Bio Limited (External organisation)

Hunter, I. (Member)
1 Aug 2009

Activity: MembershipMembership of board

SQA (External organisation)

Hunter, I. (Member)
1 Sep 2008

Activity: MembershipMembership of committee

Impacts

Commercialisation of non-invasive wound monitoring system leads to quality of life benefits to patients.

Patricia Connolly (Participant), Iain Hunter (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

File

MGB Biopharma licensed to treat deadly infections

Colin Suckling (Participant), Iain Hunter (Participant), Alan Harvey (Participant), Simon MacKay (Participant), Curtis G. Gemmell (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

File